Venous or arterial samples for activated clotting time measurements: a systematic review

被引:1
|
作者
Iddawela, Sashini [1 ]
Swamy, Priti [2 ]
Member, Sajid [3 ]
Harky, Amer [4 ,5 ,6 ,7 ,8 ]
机构
[1] Univ Hosp Birmingham, Dept Resp Med, Birmingham, W Midlands, England
[2] Kings Coll London, GKT Sch Med Educ, London, England
[3] Univ Cent Lancashire, Lancashire Sch Med & Dent, Greenbank Bldg, Preston, Lancs, England
[4] Liverpool Heart & Chest Hosp, Dept Cardiothorac Surg, Thomas Dr, Liverpool L14 3PE, Merseyside, England
[5] Univ Liverpool, Fac Hlth & Iife Sci, Dept Integrat Biol, Liverpool, Merseyside, England
[6] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England
[7] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England
[8] Alder Hey Children Hosp, Dept Cardiac Surg, Liverpool, Merseyside, England
来源
PERFUSION-UK | 2021年 / 36卷 / 08期
关键词
clotting factors; ACT; venous; arterial; cardiac surgery; cardiac catheterisation; COAGULATION TIME; HEPARIN; THROMBOELASTOGRAPHY; SURGERY;
D O I
10.1177/0267659120967836
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The systematic review aims to investigate the effect of sampling source on activated clotting time (ACT) measurement within cardiovascular surgery and cardiac catheterisation. It also examines the evidence surrounding novel clot assessment techniques and associated sampling variation. Methods: A comprehensive electronic search was conducted using PubMed, MEDLINE, Scopus, Cochrane database, and Google Scholar until 20th June 2020. All studies reporting sampling source variability of ACT in cardiac surgery, vascular surgery and cardiac catheterisation were included. Results: Fourteen studies were included in the systematic review. Inconsistent reports of variability were seen in cardiac surgery and cardiac catheterisation. There were no studies directly examining ACT variability in vascular surgery. Novel clot assessment techniques have been validated in cardiac surgery, but measurements vary depending on sampling source. Conclusion: Sampling source should be kept consistent to facilitate effective haemostatic strategies. More research is needed regarding variability in vascular surgery and novel clot assessment techniques.
引用
收藏
页码:845 / 852
页数:8
相关论文
共 50 条
  • [1] Percutaneous transluminal coronary angioplasty: Comparison of arterial vs Venous activated clotting time
    Pesola, GR
    Johnson, A
    Pesola, DA
    CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1996, 37 (02): : 140 - 144
  • [2] Ability of Activated Clotting Time Measurements to Monitor Unfractionated Heparin Activity During NonCardiac Arterial Procedures
    Hoebink, Max
    Steunenberg, Thomas A. H.
    Roosendaal, Liliane C.
    Wiersema, Arno M.
    Hamer, Henrike M.
    Yeung, Kak Khee
    Jongkind, Vincent
    ANNALS OF VASCULAR SURGERY, 2025, 110 : 460 - 468
  • [3] No Concluding Evidence on Optimal Activated Clotting Time for Non-cardiac Arterial Procedures
    Doganer, Orkun
    Wiersema, Arno M.
    Scholtes, Vincent
    Blankensteijn, Jan D.
    Yeung, Kak K.
    Jongkind, Vincent
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2020, 59 (01) : 137 - 147
  • [4] Unfractionated heparin and the activated clotting time in non-cardiac arterial procedures
    Roosendaal, Liliane C.
    van den Ancker, Willemijn
    Wiersema, Arno M.
    Blankensteijn, Jan D.
    Jongkind, Vincent
    JOURNAL OF CARDIOVASCULAR SURGERY, 2023, 64 (05): : 488 - 494
  • [5] The Effect of Smoking on the Activated Clotting Time and the Incidence of Complications in Noncardiac Arterial Procedures
    Roosendaal, Liliane C.
    van Os, Tristan E. K.
    van Es, N.
    Hoebink, M.
    Wiersema, Arno M.
    Blankensteijn, Jan D.
    Jongkind, Vincent
    JOURNAL OF ENDOVASCULAR THERAPY, 2023,
  • [6] Minimum discard volume to obtain reliable activated clotting time from the heparinized arterial line
    Erden, Ismail Aydin
    Ayhan, Banu
    Oz, Goksen
    Kanbak, Meral
    Celebioglu, Bilge
    Aypar, Ulku
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2012, 20 (04): : 794 - 798
  • [7] Reproducibility and variability of activated clotting time measurements in the cardiac catheterization laboratory
    Doherty, TM
    Shavelle, RM
    French, WJ
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2005, 65 (03) : 330 - 337
  • [8] A comparative analysis of four activated clotting time measurement devices in cardiac surgery with cardiopulmonary bypass
    Li, Han
    Serrick, Cyril
    Rao, Vivek
    Yip, Paul M.
    PERFUSION-UK, 2021, 36 (06): : 610 - 619
  • [9] Arterial versus venous sampling for activated coagulation time measurements during cardiac surgery: A comparative study
    Leyvi, G
    Zhuravlev, I
    Inyang, A
    Vinluan, J
    Ramachandran, S
    Lehning, EJ
    Wasnick, JD
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2004, 18 (05) : 573 - 580
  • [10] Con: Activated Clotting Time Should Not Be Monitored During Heparinization for Vascular Surgery
    Wolo, Elizabeth
    Herman, Corey
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2018, 32 (03) : 1497 - 1499